Zhang, Haiqiong
Wang, Jingnan
Li, Nan
Zhang, Yue
Cui, Jie
Huo, Li
Zhang, Hui
Funding for this research was provided by:
CAMS fund for Rare Diseases Research (No. 2016ZX310174-4)
Tsinghua University and PUMCH joint fund (No. PTQH201906006)
National Key Research and Development Program of China (No. 2020YFC2002702)
Tsinghua University Initiative Scientific Research Program (No. 20191080605)
Article History
Received: 17 October 2022
Accepted: 3 February 2023
First Online: 27 February 2023
Declarations
:
: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013), and all the experimental protocols were approved by the institutional review board of Peking Union Medical College Hospital as well as the requirement for informed consent was waived by the institutional review board of Peking Union Medical College Hospital since this was a retrospective study.
: Not applicable.
: Nan Li, Yue Zhang and Jie Cui are employees of SinoUnion Healthcare, which owns the property of the presented MLAA reconstruction program. Hui Zhang serves as a member of the Board of Directors of SinoUnion Healthcare. No other potential conflicts of interest relevant to this article are reported.